Followers | 42 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |
Friday, September 23, 2022 7:37:57 AM
Spero Therapeutics Raised to Outperform From In-Line by Evercore ISI Group
Ratings actions from Benzinga: https://www.benzinga.com/stock/SPRO/ratings
(END) Dow Jones Newswires
September 23, 2022 04:52 ET (08:52 GMT)”
“4:42a ET 9/23/2022 - Benzinga
Evercore ISI Group Upgrades Spero Therapeutics to Outperform, Raises Price Target to $8
Evercore ISI Group analyst Josh Schimmer upgrades Spero Therapeutics (NASDAQ:SPRO) from In-Line to Outperform and raises the price target from $2 to $8.
Latest Ratings for SPRO DateFirmActionFromTo
Oct 2021OppenheimerDowngradesOutperformPerform Jan 2021HC Wainwright & Co.MaintainsBuy Dec 2020BerenbergInitiates Coverage OnBuy
View More Analyst Ratings for SPRO
View the Latest Analyst Ratings
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
my posts are always theory and not financial advice
Recent SPRO News
- Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024 • GlobeNewswire Inc. • 10/16/2024 08:05:00 PM
- Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy • GlobeNewswire Inc. • 10/02/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 10:56:05 AM
- Spero Therapeutics to Present at Upcoming September Investor Conferences • GlobeNewswire Inc. • 09/04/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 10:43:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 10:42:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 11:56:12 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/05/2024 08:25:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 08:18:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:13:08 PM
- Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update • GlobeNewswire Inc. • 08/05/2024 08:01:00 PM
- Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024 • GlobeNewswire Inc. • 07/29/2024 08:05:16 PM
- Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/03/2024 05:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:15:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:25:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:02:29 PM
- U.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices Drop • IH Market News • 05/15/2024 11:50:05 AM
- Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 01:05:00 PM
- Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections • GlobeNewswire Inc. • 02/28/2024 01:05:00 PM
- Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference • GlobeNewswire Inc. • 02/26/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:05:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 01:53:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 01:50:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 01:45:12 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM